BBIO
BridgeBio Pharma Inc
67.30$
+0.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 9.3% | 0.0% | – | – | 0.0% | 0.0% | – | 0.2% | 62.0% | 12.0% | 79.6% | 0.9% | 218.6% | 34.6% | 35.7% | 36.5% | 14.6% | 34.3% | 0.3% | 27.6% | 21.9% | 35.4% | 2.3% | 3.3% | 5.4% | 10.0% | 5.4% | 6.8% | 6.9% | |
| – | – | – | – | – | – | 90.7% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 99.8% | 38.0% | 88.0% | 20.4% | 99.1% | -118.6% | 65.4% | 64.3% | 63.5% | 85.4% | 65.7% | 99.7% | 72.4% | 78.1% | 64.6% | 97.7% | 96.7% | 94.6% | 90.0% | 94.6% | 93.2% | 93.1% | |
| – | – | – | – | – | – | 206.7% | 416.0% | 493.7% | – | 1,132.6% | 73,913.1% | 26,527.9% | 188.7% | 4,449.9% | 948.3% | 6,354.7% | 147.0% | 27,370.1% | 4,861.1% | 5,085.5% | 6,550.2% | 3,058.8% | 7,462.8% | 66.8% | 5,290.4% | 4,408.6% | 2,216.1% | 95.5% | 100.6% | 93.5% | 92.1% | 65.1% | 67.2% | 76.7% | |
| – | – | – | – | – | – | 87.9% | 253.1% | 247.9% | – | 443.2% | 30,686.1% | 9,828.4% | 85.1% | 1,966.0% | 352.4% | 2,580.5% | 49.4% | 9,227.2% | 1,703.9% | 1,703.6% | 2,201.2% | 874.5% | 2,726.8% | 31.2% | 2,745.5% | 2,519.0% | 1,611.4% | 91.2% | 116.8% | 114.0% | 102.5% | 84.3% | 83.7% | 93.4% | |
| – | – | – | – | – | – | 294.6% | 669.1% | 741.6% | – | 1,575.8% | 104,599.2% | 36,356.3% | 273.8% | 6,415.9% | 1,373.2% | 10,273.0% | 207.8% | 38,081.4% | 6,976.2% | 6,973.6% | 8,966.5% | 3,940.0% | 10,232.8% | 99.6% | 8,169.2% | 7,096.8% | 3,907.3% | 187.2% | 218.1% | 214.9% | 210.1% | 149.1% | 141.4% | 171.7% | |
| – | – | – | – | – | – | -203.9% | -569.1% | -741.6% | – | -1,475.8% | -104,499.2% | -36,256.3% | -174.0% | -6,377.9% | -1,285.2% | -10,252.5% | -108.7% | -38,200.0% | -6,910.8% | -6,909.3% | -8,903.0% | -3,854.6% | -10,167.1% | 0.2% | -8,096.8% | -7,018.7% | -3,842.7% | -89.5% | -121.4% | -120.3% | -120.1% | -54.5% | -48.1% | -78.6% | |
| – | – | – | – | – | – | 7.9% | 22.0% | 29.0% | – | 134.5% | 8,985.2% | 2,107.8% | 20.1% | 472.1% | 117.4% | 1,200.9% | 27.5% | 5,865.4% | 1,069.0% | 1,101.9% | 1,255.0% | 496.4% | 1,161.5% | 11.1% | 1,058.0% | 844.1% | 507.0% | 36.1% | 34.0% | 9.7% | 7.8% | 27.2% | 6.0% | 13.0% | |
| – | – | – | – | – | – | -226.9% | -609.0% | -753.2% | – | -1,601.7% | -110,676.2% | -37,030.7% | -188.9% | -6,869.3% | -1,181.8% | -11,884.9% | -3.5% | -41,477.2% | -7,517.1% | -7,816.6% | -9,793.0% | -4,387.4% | -9,760.9% | -17.1% | -3,484.5% | -6,012.2% | -4,526.3% | -145.4% | -164.3% | -154.5% | -127.9% | -85.6% | -70.1% | -102.1% | |
| – | – | – | – | – | – | -20.8% | 125.2% | -73.5% | – | -50.1% | 34,196.7% | 1,623.6% | 9.0% | 226.2% | 117.4% | 2,678.9% | -84.0% | 2,432.8% | 823.7% | 1,868.2% | 1,174.0% | -40.1% | 1,052.0% | -0.4% | -96.3% | – | 19.6% | 1.9% | 1.9% | -1.3% | – | – | -2.8% | – | |
| – | – | – | – | – | – | -224.3% | -531.6% | -664.7% | – | -1,425.6% | -98,345.1% | -35,298.5% | -178.3% | -6,652.5% | -1,142.1% | -11,593.7% | -13.4% | -40,632.8% | -7,357.8% | -7,675.6% | -9,622.1% | -4,326.5% | -9,636.0% | -16.7% | -3,388.2% | -5,931.2% | -4,506.1% | -143.5% | -164.5% | -151.4% | -127.9% | -84.3% | -68.4% | -100.6% | |
| – | – | – | – | – | – | -217.6% | -584.2% | -720.2% | – | -1,463.0% | -101,334.4% | -34,800.4% | -162.4% | -6,385.8% | -1,052.5% | -10,572.7% | 26.2% | -35,125.1% | -6,359.4% | -6,625.3% | -8,438.3% | -3,851.0% | -8,508.6% | -5.3% | -2,353.9% | -5,111.8% | -3,996.1% | -108.2% | -129.1% | -143.6% | -116.9% | -57.9% | -61.4% | -87.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.